Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.701
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.159
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Organ Weight / Spleen weight
|
HOM
|
5f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.267
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Platelet count
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0221
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0633
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.104
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.582
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.600
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.249
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.148
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
4.70×10-06
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0496
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.362
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.887
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0535
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0269
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0472
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.428
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.105
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
10f:10m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.286
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.446
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.516
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.877
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.148
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.161
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.151
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Organ Weight / Spleen weight
|
HOM
|
5f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.115
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.915
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.889
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.492
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.560
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00339
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.201
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0306
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00191
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Platelet count
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.845
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0280
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.545
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.497
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00675
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.216
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.837
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000853
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.258
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
15f:15m
|
Linear Mixed Model framework, LME, not including Weight
|
0.662
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.154
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.947
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.468
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.974
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0653
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.182
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.609
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00297
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00145
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.335
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.442
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.601
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
7.75×10-05
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0331
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0234
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0364
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00948
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.506
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.450
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
6f:6m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000138
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
15f:15m
|
Linear Mixed Model framework, LME, including Weight
|
0.626
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
15f:15m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0355
|
Successful |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Klrb1tm1b(EUCOMM)Wtsi
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.750
|
Successful |